High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes.

Clinical differential diagnosis of early-onset dementia (EOD) includes familial Alzheimer disease (FAD) and hereditary prion disease. In both disease entities, postmortem brain histopathological examination is essential for unambiguous diagnosis. Mutations in the genes encoding the presenilins (PS1 and PS2) and amyloid precursor protein (APP) are associated with FAD, whereas mutations in the prion protein (PrP) gene are associated with prion disease. To investigate the proportion of EOD attributable to known genes, we prospectively (i.e., antemortem) screened these four genes for mutations by sequencing genomic PCR products from patients with EOD before age 60 years. Family history for dementia was positive (PFH) in 16 patients, negative (NFH) in 17 patients, and unknown (UFH) in 3 patients. In 12 patients, we found five novel mutations (in PS1, F105L; in PS2, T122P and M239I; and in PrP, Q160X and T188K) and five previously reported mutations (in APP, in three patients who were most likely unrelated, V717I; in PS1, A79V and M139V; and in PrP, P102L and T183A) that are all considered to be disease causing. Of these 12 patients, 9 had PFH. This indicates a detection rate of 56% (9/16) in patients with PFH. We found two mutations (APP V717I) in two of the three UFH patients, and only one mutation (PrP T188K) in 1 of the 17 patients with NFH. We conclude that because of the lack of specific antemortem diagnostic markers for FAD and hereditary prion disease, all four genes should be included in a molecular diagnostic program in patients with EOD who had PFH.

[1]  U. Finckh,et al.  Prenatal diagnosis of carbamoyl phosphate synthetase I deficiency by identification of a missense mutation in CPS1 , 1998, Human mutation.

[2]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[3]  R. Mayeux,et al.  Heterogeneity in dementia of the Alzheimer type , 1985, Neurology.

[4]  D. Pollen,et al.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.

[5]  P Brown,et al.  Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. , 1992, Science.

[6]  J. Hardy,et al.  Chromosome 14–encoded Alzheimer's disease: Genetic and clinicopathological description , 1994, Annals of neurology.

[7]  J. Hardy,et al.  Genetic classification of primary neurodegenerative disease. , 1998, Science.

[8]  H. Budka,et al.  The Original Gerstmann‐Sträussler‐Scheinker Family of Austria: Divergent Clinicopathological Phenotypes but Constant PrP Genotype , 1995, Brain pathology.

[9]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[10]  L. Harrell,et al.  SSCP analysis and sequencing of the human prion protein gene (PRNP) detects two different 24 bp deletions in an atypical Alzheimer's disease family. , 1995, American journal of medical genetics.

[11]  D. Geldmacher,et al.  Differential diagnosis of Alzheimer's disease , 1997, Neurology.

[12]  G. Schellenberg,et al.  Wide range in age of onset for chromosome 1‐related familial Alzheimer's disease , 1996, Annals of neurology.

[13]  G. Deuschl,et al.  Early-onset Alzheimer’s disease due to mutations of the presenilin-1 gene on chromosome 14: a 7-year follow-up of a patient with a mutation at codon 139 , 1998, European Archives of Psychiatry and Clinical Neuroscience.

[14]  J. Rommens,et al.  Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene , 1995, Nature.

[15]  G. Lenzi,et al.  Polymorphism at codon 129 or codon 219 of PRNP and clinical heterogeneity in a previously unreported family with Gerstmann-Straussler-Scheinker disease (PrP-P102L mutation) , 1996, Neurology.

[16]  Takashi Asada,et al.  Familial Alzheimer's disease genes in Japanese , 1998, Journal of the Neurological Sciences.

[17]  S. Prusiner,et al.  Molecular cloning of a human prion protein cDNA. , 1986, DNA.

[18]  J. Rinne,et al.  The Glu318Gly mutation of the presenilin‐1 gene does not necessarily cause Alzheimer's disease , 1998, Annals of neurology.

[19]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[20]  T. Crow,et al.  INSERTION IN PRION PROTEIN GENE IN FAMILIAL CREUTZFELDT-IAKOB DISEASE , 1989, The Lancet.

[21]  B. Ghetti,et al.  Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Pericak-Vance,et al.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.

[23]  J. Rommens,et al.  Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant. , 1996, Human molecular genetics.

[24]  Nick C Fox,et al.  Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor. , 1997, Brain : a journal of neurology.

[25]  R. Rozmahel,et al.  Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of β-catenin,a component of the presenilin protein complex , 1999, Nature Medicine.

[26]  T. Kitamoto,et al.  An amber mutation of prion protein in Gerstmann-Sträussler syndrome with mutant PrP plaques. , 1993, Biochemical and biophysical research communications.

[27]  D. Gajdusek,et al.  Mixed features of Alzheimer disease and Creutzfeldt-Jakob disease in a family with a presenilin 1 mutation in chromosome 14 , 1996 .

[28]  M. Palmer,et al.  Deletions in the prion protein gene are not associated with CJD. , 1993, Human molecular genetics.

[29]  A Hofman,et al.  Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. , 1998, Human molecular genetics.

[30]  M. Bullido,et al.  Missense mutation E318G of the presenilin‐1 gene appears to be a nonpathogenic polymorphism , 1998, Annals of neurology.

[31]  A. Hofman,et al.  The Glu318Gly substitution in presenilin 1 is not causally related to Alzheimer disease. , 1999, American journal of human genetics.

[32]  M. Passos-Bueno,et al.  Familial spongiform encephalopathy associated with a novel prion protein gene mutation , 1997, Annals of neurology.

[33]  K. Eguchi,et al.  Discordant Gerstmann-Sträussler-Scheinker disease in monozygotic twins , 1998, The Lancet.

[34]  G. Schellenberg,et al.  Candidate gene for the chromosome 1 familial Alzheimer's disease locus , 1995, Science.

[35]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[36]  Jurg Ott,et al.  Linkage of a prion protein missense variant to Gerstmann–Sträussler syndrome , 1989, Nature.

[37]  K. Jellinger,et al.  Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease , 1998, Acta Neuropathologica.

[38]  B. Ghetti,et al.  Gerstmann-Sträussler-Scheinker disease with the PRNP P102L mutation and valine at codon 129. , 1997, Brain research. Molecular brain research.